They are among the several South African HIV/AIDS healthcare providers that have been confused, angry, and scrambling for survival since U.S. President Donald Trump issued a 90-day freeze last ...
The U.S. said a waiver on halting some activities in South Africa under the President’s Emergency Plan for AIDS Relief, or PEPFAR, will focus on “life-saving” treatments.
An alliance of SA civil society groups has called on President Cyril Ramaphosa to personally intervene in the HIV funding ...
Image: South Africa is home to one of the world's worst HIV/AIDS epidemics On the day he was sworn in as US president for a second time, Donald Trump signed an executive order freezing foreign aid ...
HIV Latency Reversing Properties in African Plant Nov. 19 ... reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world ...
Some South African organizations ... the money poured into expert HIV care here, 17% of which comes from a U.S. program called the President's Emergency Plan for AIDS Relief, also known as PEPFAR.
South Africa is home to one of the world's worst HIV/AIDS epidemics. At least 8.5 million people here are living with HIV - and now their treatment is in doubt thanks to Trump's executive order to ...
This should ensure that HIV treatment dispersed by PEPFAR continues, according to the International AIDS Society ... Gladys Kiio, executive director at African Gender and Media Initiative Trust ...
Johannesburg, South Africa — Some ... money poured into expert HIV care here, 17% of which comes from a U.S. program called the President's Emergency Plan for AIDS Relief, also known as PEPFAR.
Trump’s 90-day foreign aid freeze has left many South Africans without essential HIV treatment, affecting a quarter of global ...
AIDS-free, Mentored and Safe).” The funding structure for South Africa’s HIV response relies heavily on domestic resources, with the government providing 74% of overall funding, while ...
Staying Golden: Aging With HIV: The Way Forward A longtime HIV/AIDS researcher and clinician maps out potential ways to approach a curative strategy, and comments on the need for global resources ...